About | Free Trial

Last Update

2016-02-26T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Samuel Strober?

Dr. Samuel Strober

Professor of Medicine

Stanford University

Direct Phone: (650) ***-****       

Email: s***@***.edu

Stanford University

857 Serra Street, Suite 210

Stanford, California 94305

United States

Company Description

Stanford University Medical Center integrates research, medical education and patient care at its three institutions â€" Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children's Hospital at Stanford. ... more

Find other employees at this company (49,148)

Background Information

Employment History

Chairman
LIAI

Professor of Medicine and Chief
Howard Hughes Medical Institute

President
Clinical Immunology Society

Research Associate In the Laboratory of Cell Biology
National Cancer Institute

Affiliations

Board Member
Medeor Therapeutics Inc

Founder
Dendreon Corporation

Education

B.A.

Columbia University

M.D.

Harvard University

Web References (69 Total References)


Samuel Strober, ...

www.medeortherapeutics.com [cached]

Samuel Strober, M.D. Scientific Founder and Board Member

Dr. Strober is Professor of Medicine at Stanford University School of Medicine and former Chief of the Division of Immunology and Rheumatology. He has been President of the Clinical Immunology Society, Chairman of the Board of the La Jolla Institute for Allergy and Immunology and was a scientific founder of Dendreon Corporation. Dr. Strober's research has focused on the immune cell interactions that prevent rejection of organ transplants in the absence of immunosuppressive drugs as well as cell interactions that prevent graft versus host disease and retain graft anti-tumor activity after hematopoietic cell transplantation. Dr. Strober has published over 300 peer-reviewed articles in scientific journals, is the inventor of multiple patented technologies, and has served on editorial boards of immunology journals
He received his B.A. from Columbia University and his M.D. from Harvard University.


Engleman teamed up with fellow ...

www.pir-resourcing.com [cached]

Engleman teamed up with fellow Stanford immunologist Samuel Strober to work out ways to make the process more efficient.

...
When the two pitched their idea for a company to investors, they had little clinical data and were too optimistic about how fast the treatment could reach patients, says Strober. The company was an enormous gamble: harnessing the immune system to fight cancer was still a controversial idea, and no other company had marketed a therapy so personalized and labour-intensive. "But at that time it was a little different from now," says Strober. "Companies were getting funded on the basis of promise, rather than actually looking at their capacity for early commercial success."
Engleman and Strober founded Dendreon in 1992; the US Food and Drug Administration approved Provenge in 2010.
...
"We're thinking that this one will progress a lot faster than the Dendreon thing," says Strober.


Engleman teamed up with fellow ...

www.nature.com [cached]

Engleman teamed up with fellow Stanford immunologist Samuel Strober to work out ways to make the process more efficient.

...
When the two pitched their idea for a company to investors, they had little clinical data and were too optimistic about how fast the treatment could reach patients, says Strober. The company was an enormous gamble: harnessing the immune system to fight cancer was still a controversial idea, and no other company had marketed a therapy so personalized and labour-intensive. "But at that time it was a little different from now," says Strober. "Companies were getting funded on the basis of promise, rather than actually looking at their capacity for early commercial success."
Engleman and Strober founded Dendreon in 1992; the US Food and Drug Administration approved Provenge in 2010.
...
"We're thinking that this one will progress a lot faster than the Dendreon thing," says Strober.


Engleman teamed up with fellow ...

www.pir-resourcing.com [cached]

Engleman teamed up with fellow Stanford immunologist Samuel Strober to work out ways to make the process more efficient.

...
When the two pitched their idea for a company to investors, they had little clinical data and were too optimistic about how fast the treatment could reach patients, says Strober. The company was an enormous gamble: harnessing the immune system to fight cancer was still a controversial idea, and no other company had marketed a therapy so personalized and labour-intensive. "But at that time it was a little different from now," says Strober. "Companies were getting funded on the basis of promise, rather than actually looking at their capacity for early commercial success."
Engleman and Strober founded Dendreon in 1992; the US Food and Drug Administration approved Provenge in 2010.
...
"We're thinking that this one will progress a lot faster than the Dendreon thing," says Strober.


La Jolla Institute for Allergy & Immunology | Board of Directors

www.liai.org [cached]

SAMUEL STROBER, M.D. Professor of Medicine, Division of Immunology and Rheumatology Stanford University School of Medicine

Dr. Strober has served as Professor of Medicine at Stanford University School of Medicine, Division of Immunology and Rheumatology, since 1982. He held the position of Chief of that Division from 1978 to 1997, having first arrived at the School of Medicine as a Senior Assistant Resident in 1970. He has been President of the Clinical Immunology Society, and is a founder of two biotechnology companies (Dendreon, Inc. and Innate Immune, Inc.)
Dr. Strober's laboratory research and clinical trials have focused on the immune cell interactions that prevent graft versus host disease and retain graft anti-tumor activity after bone marrow transplantation, as well as cell interactions that prevent rejection of organ transplants in the absence of immunosuppressive drugs. He is also interested in the pathogenesis of systemic lupus erythematosus, a disease in which the immune system causes excessive inflammation leading to the damage of multiple organs. Throughout his career, Dr. Strober has published over 300 peer-reviewed articles in scientific journals, and has served on editorial boards of immunology journals. He received the Leon Reznick Memorial Prize from the Harvard Medical School.
Dr. Strober received his B.A. from Columbia University and his M.D. from Harvard University. He completed fellowships in the Surgical Research Laboratory at the Peter Bent Brigham Hospital in Boston, and in the Sir William Dunn School of Pathology in Oxford University followed by an internship in medicine at Massachusetts General Hospital. Prior to joining Stanford, Dr. Strober completed additional postdoctoral training as a Research Associate in the Laboratory of Cell Biology of the National Cancer Institute, Bethesda.

Similar Profiles

Other People with this Name

Other people with the name Strober

Lauren Strober
Kessler Foundation

Kerri Strober
Fender

Andy Strober
Wonderland Wizards Youth Hockey Association

Steven Strober
Maintenance LLC

Jennifer Strober
Starr Mortgage Company, Inc.

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory